Publisher： John Wiley & Sons Inc
E-ISSN： 1931-2253|29|2|37-39
ISSN： 0959-6682
Source： PRESCRIBER, Vol.29, Iss.2, 2018-02, pp. : 37-39
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis
ANNALS OF NEUROLOGY, Vol. 77, Iss. 3, 2015-03 ,pp. :
Access to resources
Recommend
Cladribine tablets and multiple sclerosis: NICE technology appraisal
PROGRESS IN NEUROLOGY AND PSYCHIATRY, Vol. 22, Iss. 1, 2018-01 ,pp. :
Teriflunomide for relapsing remitting multiple sclerosis
PRESCRIBER, Vol. 26, Iss. 18, 2015-09 ,pp. :
Emerging Therapies in Relapsing-Remitting Multiple Sclerosis
Reviews on Recent Clinical Trials, Vol. 5, Iss. 3, 2010-09 ,pp. :
Cladribine Treatment of a Patient with Hairy Cell Leukemia and Concomitant Multiple Sclerosis
Acta Haematologica, Vol. 102, Iss. 2, 1999-10 ,pp. :